Drug Profile


Alternative Names: Arbetuzole; R 58735

Latest Information Update: 26 Sep 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Janssen L.P.
  • Class Neuroprotectants; Nootropics
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Alzheimer's disease; Diabetic neuropathies

Most Recent Events

  • 08 Jan 2001 Discontinued-Clinical for Alzheimer's disease in United Kingdom (PO)
  • 08 Jan 2001 Discontinued-II for Alzheimer's disease in Canada (PO)
  • 08 Jan 2001 Discontinued-III for Alzheimer's disease in Belgium (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top